or Try an Advanced Search...

    Severe Plaque Psoriasis Stocks List

    Symbol Grade Name % Change
    BIIB D Biogen Idec Inc. 0.44
    ABBV D AbbVie Inc. -1.12
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major
    Related Stock Lists: Immunosuppressants Psoriasis S&P 500 Adalimumab Advanced Prostate Cancer Alzheimer's Disease Anemia Atopic Dermatitis Autoimmune Disease Autoimmune Disorders Biotechnology Blood Cancers Cd20 Chronic Idiopathic Constipation Chronic Lymphocytic Leukemia Clinical Trial Product Clinical Trial Products Combination Drugs Constipation Crohn's Disease

    Related ETFs - A few ETFs which own one or more of the above listed Severe Plaque Psoriasis stocks.

    Symbol Grade Name Weight
    MEDX C Horizon Kinetics Medical ETF 11.57
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 10.68
    MEDI D Harbor Health Care ETF 10.52
    HDLB A ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    PJP A PowerShares Dynamic Pharmaceuticals 9.05
    View all Severe Plaque Psoriasis ETFs...
    Compare ETFs
    Compare MEDI to HDLB Compare MEDX to FTXH Compare MEDX to HDLB

        Severe Plaque Psoriasis Stocks Recent News

        Date Stock Title
        May 18 ABBV Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
        May 17 BIIB Ionis, Biogen Down on Ending Development of ALS Drug
        May 17 ABBV AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst
        May 17 BIIB Ionis (IONS), Biogen Down on Ending Development of ALS Drug
        May 17 ABBV Robinhood upgraded, Baidu downgraded: Wall Street's top analyst calls
        May 17 ABBV AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®
        May 16 ABBV AbbVie CEO latest heavy hitter to buy in Boca Raton
        May 16 BIIB Biogen also drops collaboration with Ionis on Angelman syndrome candidate
        May 16 BIIB Biogen and Ionis drop ALS candidate after trial setback
        May 16 BIIB Biogen, Ionis shelve ALS drug following study failure
        May 16 BIIB REFILE-UPDATE 2-Biogen, Ionis to discontinue development of experimental ALS drug
        May 16 BIIB Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 16 BIIB Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
        May 15 ABBV AbbVie, Inc. (ABBV) Bank of America Health Care Conference Call Transcript
        May 15 BIIB Eisai projects major growth for Alzheimer's therapy Leqembi
        May 15 BIIB Biogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
        May 15 BIIB Biogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
        May 15 BIIB Eisai sets new revenue target for Alzheimer’s drug Leqembi
        May 15 BIIB Biogen partner Eisai begins FDA submissions for injectable Alzheimer’s therapy
        May 15 ABBV NeuroSense taps PhaseV’s ML tech for Phase III ALS trial analysis
        Related Industries: Drug Manufacturers - Major
        Related Stock Lists: Immunosuppressants Psoriasis S&P 500 Adalimumab Advanced Prostate Cancer Alzheimer's Disease Anemia Atopic Dermatitis Autoimmune Disease Autoimmune Disorders Biotechnology Blood Cancers Cd20 Chronic Idiopathic Constipation Chronic Lymphocytic Leukemia Clinical Trial Product Clinical Trial Products Combination Drugs Constipation Crohn's Disease
        Severe Plaque Psoriasis

        Browse All Tags